Latest news on Alzheimer's

The researcher defended the thesis, developed at the BBRC and focused on biomarkers in preclinical Alzheimer's fluids, in April 2022.

The data have been compared with Alzheimer's biomarkers of 2,300 people from four cohorts, including participants without cognitive alterations from the ALFA Study, promoted by the ”la Caixa” Foundation.

Researchers from the research center of the Pasqual Maragall Foundation have taken part in these conferences dedicated to the latest developments in Alzheimer's research and the future of the European EPAD and AMYPAD projects.

More than 80 researchers have attended the Biomarkers Workshop, a scientific event with great international impact, organised by the Barcelonaβeta Brain Research Center.

Thanks to this neuroimaging technique, widely used in the field of research, deposits of the Alzheimer’s disease associated amyloid-β protein in the brain can be detected and evaluated.

The sessions, directed by the research center of the Pasqual Maragall Foundation, will feature presentations by leading experts in the field of neuroscience.

The results of the study, promoted by the ”la Caixa” Foundation, show the value of regional amyloid PET analysis to detect cognitive impairment in people who carry the APOE-ε4 gene

The objective of the document is to guide the growth and adaptation of the entity to the new scientific and institutional challenges, and to establish priorities that will be developed in the center during the next five years.

Our research center opens a new information channel aimed at scientific research institutions and researchers in the sector.